Managing inflammatory bowel disease at Sinai Health

Image
Managing inflammatory bowel disease at Sinai Health

Research shows that 1 in 150 Canadians have Inflammatory Bowel Disease or IBD, making Canada one of the countries with the highest prevalence rates in the world.

IBD, including Crohn’s disease and ulcerative colitis, is an umbrella term used to describe conditions that result in chronic inflammation of the gastrointestinal tract. Patients can experience debilitating pain, fatigue and unintentional weight loss, which causes a significant impact on quality of life.

The cause of IBD is currently unknown and there is no cure, but great strides have been made to understand the disease and, through medication and surgery, manage its symptoms.

Throughout February, we’ll highlight stories of world-leading care and research for Inflammatory Bowel Disease. You will hear from our researchers and front-line colleagues who work to improve the quality of life for patients with IBD.

  • We are renowned for delivering excellence in patient care, education and research for patients with disorders of the gastrointestinal tract (esophagus, stomach, pancreas, liver, small intestine, and colon)
  • Mount Sinai Hospital’s Centre for Inflammatory Bowel Disease serves over 4,700 patients annually, many from outside of Toronto and Ontario
  • The Zane Cohen Centre for Digestive Diseases (ZCC) is internationally acclaimed as a clinical research facility in the understanding and treatment of gastrointestinal diseases

We are leaders

Image
icon for doctor

We provide specialized consultation services to complex IBD patients across Ontario, providing care to individuals living in remote and rural Ontario communities through our telemedicine program

Image
icon for patients

Our Centre for Inflammatory Bowel Disease is Ontario’s tertiary referral centre for patients with complex IBD

Image
icon for hospital

We are the National Referral Centre for minimally invasive pouch surgery, a revolutionary surgical technique pioneered by Mount Sinai Hospital’s Dr. Zane Cohen

Image
icon for global

Mount Sinai Hospital’s Dr. Ken Croitoru leads the Genetic Environmental and Microbial (GEM) Project, a global research study that looks to uncover the cause of Crohn’s disease

To learn more, stay tuned here and across our social media channels throughout the month and follow the hashtags #SinaiStories and #SinaiResearch.

Find another story: